RESQ PHARMACEUTICALS INC. — Form D
RESQ PHARMACEUTICALS INC. of HENDERSON, NV, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-23. The offering totals $2.0M, of which $247K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-04-23
- Form: D
- Accession: 0001805243-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06c, 04.3
- Total offering: $2.0M
- Amount sold: $247K
- Remaining: $1.8M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2020-04-07
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-365676
Issuer
- Name: RESQ PHARMACEUTICALS INC.
- CIK: 0001805243
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3535 EXECUTIVE TERMINAL DRIVE, HENDERSON, NV, 89052
- Phone: (701) 541-9222
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ben T Esque | Executive Officer | Haleiwa, HI |
| John T Hyatt | Promoter | Haleiwa, HI |
| BEN ESQUE | Director | HENDERSON, NV |
| BEN ESQUE | Executive Officer | HENDERSON, NV |
Other filings by this issuer (1)
More